Speech-Language Pathologists in Shelbyville, IL Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Tina Vogel Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2201 W Main St, Shelbyville, IL 62565 Phone: 877-978-2174

Mrs. Lacy D. Houska, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2099 E 875 North Rd, Shelbyville, IL 62565 Phone: 217-774-1456

Mrs. Ashley Elizabeth Lockart, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 W North 3rd St, Shelbyville, IL 62565 Phone: 217-273-8891

Marnelle Kathryn Oligschlaeger, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1101 Wn 6th St, Shelbyville, IL 62565 Phone: 217-774-2169

Mrs. Rebecca Lynn Miller, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Green Acres, Shelbyville, IL 62565 Phone: 217-774-5574

Corrin Reimer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 154b, Shelbyville, IL 62565 Phone: 217-774-2428    Fax: 217-774-4136

Mrs. Stephanie Marie Aberle Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 W North 12th St, Shelbyville, IL 62565 Phone: 217-774-2111

News Archive

Montefiore-Einstein investigators to present new findings from eight abstracts at IFHNOS 2014

Clinicians and researchers from Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University will present new findings from eight abstracts at the International Federation of Head and Neck Oncologic Societies World Congress being held July 26 - July 30 in New York.

Research identifies SARS-CoV-2 cavities as potential drug targets

New research found the SARS-CoV-2 spike glycoprotein has druggable cavities with the best target being compatible with more than 1 billion compounds.

Study suggests optimal length of opioid pain prescriptions for common surgical procedures

Findings from an analysis that included more than 200,000 patients who underwent common surgical procedures suggests that the optimal length of opioid pain prescriptions is four to nine days for general surgery procedures, four to 13 days for women's health procedures, and six to15 days for musculoskeletal procedures, according to a study published by JAMA Surgery.

Health care legislation not fair to Hispanic small businesses and families

A number of Hispanic organizations have united to address major problems with the health care legislation passed in the U.S. House of Representatives and urge the Senate to come up with a bipartisan solution for real healthcare reform. They are especially concerned the health care legislation will create a greater tax burden and unfair government mandates on Hispanic small businesses and families. During this critical health care debate, these organizations want their voices to be heard and believe that the current approach will lead to loss of jobs and reduced wages for Hispanic workers.

Astellas seeks FDA approval for tacrolimus NDA for prophylaxis of organ rejection

Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for tacrolimus extended release capsules for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients.

Read more Medical News

› Verified 3 days ago